HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


P&G files suit against Fruit of the Earth

This article was originally published in The Rose Sheet

Executive Summary

Procter & Gamble claims Irving, Texas-based company infringed three patents and the trade dress for its Olay Regenerist brand. According to Dec. 12 release, Fruit of the Earth has created an entire line of look-alike products for CVS Pharmacy doors that copy Olay's well-known packaging and technology, according to P&G, which has filed suit in the United States Federal District Court for the Southern District of Ohio in Cincinnati, asking that Fruit of the Earth be ordered to stop distributing the infringing products and to notify its retailers to impound or return all products. The offending items will confuse consumers and allow Fruit of the Earth to "trade on the goodwill" established in the Olay brand, P&G says. "We believe this is a case of clear infringement designed to take advantage of consumer goodwill and business growth that P&G developed through its patented innovation on the Olay brand," Chief Legal Officer Jim Johnson says

You may also be interested in...

P&G settles with Fruit of the Earth

Ft. Worth, Texas natural personal-care and dietary supplement company recognizes the validity of P&G's rights to Olay Regenerist trade dress and related patents and agrees to revise its product offerings under a Consent Judgment announced Jan. 6. Remaining terms of the settlement were not disclosed. In December 2007, P&G alleged that a line of products created by Friends of the Earth for CVS Pharmacy locations consisted of Olay Regenerist look-alikes that infringed its packaging and technology (1"The Rose Sheet" Dec. 17, 2007, In Brief). "We don't make our Olay formulas or quality available under any store brand. P&G will continue to vigorously protect [its] proprietary formulas and the trade dress that consumers associate with the brands they trust," says P&G's Steve Jemison, chief legal officer. Separately, the firm has filed suit against RNA Corporation, Blue Cross Laboratories and Apollo Health and Beauty Care Corporation for infringement of intellectual property related to its Herbal Essences brand (2"The Rose Sheet" Dec. 22, 2008, In Brief)

Novartis Pharma President Marie-France Tschudin On Inclisiran, Launches And More

Tschudin talked to Scrip about taking over as Novartis Pharmaceuticals president, why inclisiran is different from marketed PCSK9 inhibitors and prioritizing investment behind multiple new launches.

Celebrity Takes Role In US FDA Study Of Rx Drug Endorsements

Agency hasn't named the celebrity that will participate in the study on the impact that celebrity and non-celebrity endorsements have on consumer perceptions about Rx drugs.




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts